» Articles » PMID: 38809980

Presynaptic Nanoscale Components of Retrograde Synaptic Signaling

Abstract

While our understanding of the nanoscale architecture of anterograde synaptic transmission is rapidly expanding, the qualitative and quantitative molecular principles underlying distinct mechanisms of retrograde synaptic communication remain elusive. We show that a particular form of tonic cannabinoid signaling is essential for setting target cell-dependent synaptic variability. It does not require the activity of the two major endocannabinoid-producing enzymes. Instead, by developing a workflow for physiological, anatomical, and molecular measurements at the same unitary synapse, we demonstrate that the nanoscale stoichiometric ratio of type 1 cannabinoid receptors (CBRs) to the release machinery is sufficient to predict synapse-specific release probability. Accordingly, selective decrease of extrasynaptic CBRs does not affect synaptic transmission, whereas in vivo exposure to the phytocannabinoid Δ-tetrahydrocannabinol disrupts the intrasynaptic nanoscale stoichiometry and reduces synaptic variability. These findings imply that synapses leverage the nanoscale stoichiometry of presynaptic receptor coupling to the release machinery to establish synaptic strength in a target cell-dependent manner.

Citing Articles

Synaptic Targets and Cellular Sources of CB1 Cannabinoid Receptor and Vesicular Glutamate Transporter-3 Expressing Nerve Terminals in Relation to GABAergic Neurons in the Human Cerebral Cortex.

Somogyi P, Horie S, Lukacs I, Hunter E, Sarkany B, Viney T Eur J Neurosci. 2025; 61(1):e16652.

PMID: 39810425 PMC: 11733414. DOI: 10.1111/ejn.16652.


Understanding the molecular diversity of synapses.

van Oostrum M, Schuman E Nat Rev Neurosci. 2024; 26(2):65-81.

PMID: 39638892 DOI: 10.1038/s41583-024-00888-w.


Functional Adaptation in the Brain Habenulo-Mesencephalic Pathway During Cannabinoid Withdrawal.

Aroni S, Sagheddu C, Pistis M, Muntoni A Cells. 2024; 13(21.

PMID: 39513916 PMC: 11545051. DOI: 10.3390/cells13211809.


Simulated complexes formed from a set of postsynaptic proteins suggest a localised effect of a hypomorphic Shank mutation.

Miski M, Weber A, Fekete-Molnar K, Keomley-Horvath B, Csikasz-Nagy A, Gaspari Z BMC Neurosci. 2024; 25(1):32.

PMID: 38971749 PMC: 11227168. DOI: 10.1186/s12868-024-00880-1.

References
1.
Foldy C, Neu A, Jones M, Soltesz I . Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci. 2006; 26(5):1465-9. PMC: 6675496. DOI: 10.1523/JNEUROSCI.4587-05.2006. View

2.
Tasso M, Giovanelli E, Zala D, Bouccara S, Fragola A, Hanafi M . Sulfobetaine-Vinylimidazole Block Copolymers: A Robust Quantum Dot Surface Chemistry Expanding Bioimaging's Horizons. ACS Nano. 2015; 9(11):11479-89. DOI: 10.1021/acsnano.5b05705. View

3.
Puighermanal E, Busquets-Garcia A, Gomis-Gonzalez M, Marsicano G, Maldonado R, Ozaita A . Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology. 2013; 38(7):1334-43. PMC: 3656376. DOI: 10.1038/npp.2013.31. View

4.
Baur R, Gertsch J, Sigel E . The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. Br J Pharmacol. 2011; 165(8):2479-84. PMC: 3423234. DOI: 10.1111/j.1476-5381.2011.01405.x. View

5.
Dudok B, Klein P, Hwaun E, Lee B, Yao Z, Fong O . Alternating sources of perisomatic inhibition during behavior. Neuron. 2021; 109(6):997-1012.e9. PMC: 7979482. DOI: 10.1016/j.neuron.2021.01.003. View